Adhera Drug Patent Portfolio
Adhera owns 1 orange book drug protected by 2 US patents Given below is the list of Adhera's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7846961 | α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it | 05 Oct, 2029 | Active |
| US6696481 | Salt of perindopril and pharmaceutical compositions containing it | 15 Apr, 2023 | Expired |
Latest Legal Activities on Adhera's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Adhera.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 May, 2022 | US7846961 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Apr, 2018 | US7846961 |
| Post Issue Communication - Certificate of Correction | 11 Apr, 2011 | US7846961 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Dec, 2010 | US7846961 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Dec, 2010 | US7846961 |
|
Issue Notification Mailed
Critical
| 17 Nov, 2010 | US7846961 |
| Dispatch to FDC | 11 Nov, 2010 | US7846961 |
|
Application Is Considered Ready for Issue
Critical
| 02 Nov, 2010 | US7846961 |
|
Issue Fee Payment Received
Critical
| 21 Oct, 2010 | US7846961 |
|
Issue Fee Payment Verified
Critical
| 21 Oct, 2010 | US7846961 |
|
Mail Notice of Allowance
Critical
| 27 Sep, 2010 | US7846961 |
| Mail Examiner's Amendment | 27 Sep, 2010 | US7846961 |
|
Case Docketed to Examiner in GAU
Critical
| 24 Sep, 2010 | US7846961 |
|
Notice of Allowance Data Verification Completed
Critical
| 24 Sep, 2010 | US7846961 |
| Date Forwarded to Examiner | 13 Jul, 2010 | US7846961 |
Adhera's Family Patents
Adhera drugs have patent protection in a total of 41 countries. It's US patent count contributes only to 2.9% of its total global patent coverage. Click
below to unlock the full patent family tree.
Adhera Drug List
Given below is the complete list of Adhera's drugs and the patents protecting them.
1. Prestalia
Prestalia is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7846961 | α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it |
05 Oct, 2029
(4 years from now)
| Active |
| US6696481 | Salt of perindopril and pharmaceutical compositions containing it |
15 Apr, 2023
(1 year, 9 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prestalia's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List